1 / 30

Polycystic Ovarian Syndrome

Polycystic Ovarian Syndrome. Heval Mohamed Kelli MS-3 October 27, 2010. http://www.morethancardio.com/pcos-awareness/. Definition. ACOG and NIH: hyperandrogenic chronic anovulation state excluding other causes. Anovulation + Hyperandrogenism & Exclusion of other disorders (NIH)

aram
Download Presentation

Polycystic Ovarian Syndrome

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Polycystic Ovarian Syndrome Heval Mohamed Kelli MS-3 October 27, 2010 http://www.morethancardio.com/pcos-awareness/

  2. Definition ACOG and NIH: hyperandrogenic chronic anovulation state excluding other causes. Anovulation + Hyperandrogenism & Exclusion of other disorders (NIH) Polycystic ovaries by US-nonspecific (Rotterdam 2 of 3) Originally called Stein-Leventhal Syndrome

  3. Core Features Area 1 represents subjects fulfilling the 1990 NIH criteria for PCOS. Areas 2 and 3 added by the 2003 Rotterdam criteria

  4. Incidence PCOS is one of the most common endocrine disorders of women in the reproductive age group, with a incidence of US 4-12% (NIH criteria) World wide 6.5-8% (NIH criteria) Prevalance-PCOS with Normogonadotrophic anovulation Rotterdam- 91% NIH-55% Higher in Mexican-American than White or African-American women. (No difference b/w AA & CAU women) Higher in those with gestational diabetes Those with first-degree relatives with PCOS

  5. Etiology Unknown exact cause? • A genetic disorder with an autosomal dominant mode of inheritance? • A multifactorial genetic disorder? • Hypersecretion of adrenal androgens? • Hypersecretion of ovarian androgens? • Insulin resistance-Decreased SHBG ?

  6. Pathophysiology High LH—Increased ovarian theca cells--Increase the production of androgens (testosterone, androstenedione)–Hyperandrogenism-Hirsutism/Acne.. Androstenedione aromatize to estrone within adipocytes- +feedback on Pit to secrete LH. Estrone= weak estrogen- Increased Hyperinsulinemia/Insulin resistance- pulse Increase GnRH pulse frequency, decreased SHBG--Hyperandrogenism Obesity (50% to 65% PCOS pts), may increase the insulin resistance and hyperinsulinemia

  7. Pathophysiology

  8. Pathophysiology • Hormonal Studies in Women with PCOS show: • Increased LH: FSH • Estrone greater than estradiol • Androstenedione (Dehydroepiandrosterone-sulfate (DHEA-S)) at the upper limit of normal or increased • Testosterone at the upper limit of normal or slightly increased

  9. Signs and symptoms Menstrual abnormality-Amenorrhea or Oligomenorrhea Hirsutism- Depend on ethnic groups Male pattern alopecia Acne Infertility Weight gain and obesity (50%) Insulin abnormalities-38 % IGT, 7.5% DM-II Acanthosis Nigricans- HAIR-AN syndrome (Hyperandrogenism, insulin resistance, AN) Ovarian Cysts Mood Swings, depression Sleep Apnea Absence of breast development

  10. Differential Diagnosis Androgen-excess disorders Late onset non-classic 21 hydroxylase deficiency Idiopathic hirsutism Syndromes of severe insulin resistance e.g. HAIR-AN syndrome Ovarian androgen-secreting tumours Use of anabolic or androgenic drugs Cushing’s syndrome Ovulatory disorders Hypothalamic and pituitary disorders causing amenorrhoea Premature ovarian failure Others Thyroid dysfunction Hyperprolactinaemia

  11. Complication & Risk Infertility Risk of endometrial cancer Insulin resistance & DM-II CVD Metabolic syndrome: ↑TG, WC, BP, fasting glucose & ↓HDL Obesity related disorders: Sleep apnea Mood disorders & Depression Pregnancy complications

  12. Pregnancy Gestational diabetes Large birth weight Miscarriage - 45 to 50% risk Preeclampsia Pregnancy-induced hypertension Premature birth Prenatal care Wt loss improved pregnancy rate Carefully monitoring the pregnancy and routine prenatal care. Maintaining a healthy PCOS pregnancy diet: fruits, vegetable and grains. Getting prompt intervention if complications occur

  13. Diagnosis & Work up-1 History-menstrual pattern, duration of androgen excess, hirsutism, medications, FH(DM & CVD), life styles (Tob/Etoh, exercise). Physical exam- body hair distribution, acne, temporal balding, acanthosis, pelvic exam to assess ovarian size.

  14. Diagnosis & Work up-2 Laboratory: Serum hCG- r/o pregnancy Documentation of unexplained Hyperandrogenemia Testosterone • A total testosterone more reliable than a free testosterone • AES recommends Free Test-sensitive indicator- Directly or FAI calculated based on total test & SHBG(supranormal level in 60% of PCOS pts) • Testosterone values may be normal in PCOS. • Oral contraceptives will lower total testosterone (3 months off oral contraceptives is best to get a “true” testosterone value). • Most testosterone values in PCOS will be ≤150 ng/dL (≤5.2 nmol/L). • Testosterone values of ≥200 ng/dL (≥6.9 nmol/L) warrant consideration of an ovarian or adrenal tumor.

  15. Diagnosis & Work up-3 Laboratory: Dehydroepiandrosterone-sulfate (DHEA-S)- Poor sp/sn • DHEA-S values may be normal or slightly elevated in PCOS. • DHEA-S values ≥800 µg/dL (21.7 µmol/L) warrant consideration of an adrenal tumor. • Maybe useful in cases of rapid virilization (LH/FSH) ratio-Poor sp/sn • A ratio ≥2.0 is suggestive of PCOS- poor sp/sn • Gonadotropin levels are affected by oral contraceptives FSH level- r/o primary ovarian failure

  16. Diagnosis & Work up-4 Laboratory: Evaluation of Metabolic abnormalities 75-g oral glucose-tolerance test (OGTT) -31% of PCOS pt report IGT Fasting lipid profile- often abnormal: ↓HDL, ↑LDL, ↑ TG

  17. Diagnosis & Work up-5 Laboratory: Exclusion of disorders with similar symptoms: Prolactin r/o hyperprolactinemia. Mild elevation in PCOS (5-30%pts) TSH r/o hypothyroidism 17-hydroxyprogesteron r/o Late-onset CAH -morning, fasting, unstimulated level of <200 ng/dL (<6 nmol/L) is normal. 24-hour urine free cortisolr/o Cushing syndrome. Mild elevation in PCOS

  18. Diagnosis & Work up-6 Ultrasound Polycystic ovaries are defined as 12 or more follicles in at least 1 ovary measuring 2-9 mm in diameter or a total ovarian volume of >10 cm3 The presence of one polycystic ovary is sufficient for diagnosis ID of endometerial changes. http://www.infertility.net.au/causeOvulation.htm

  19. Diagnosis & Work up-6 Ultrasound http://www.ivf-infertility.com/infertility/pcos.php

  20. Treatment Goals • Interrupt the disorder’s positive cycle. • Reduce circulating androgen levels • Protect the endometrium from unopposed estrogen (reduce risk of endometrial cancer) • Encourage weight loss and healthy lifestyle changes • Induce ovulation when pregnancy is desired • Monitor for the development of DM and CVD and Lower risk factors (smoking cessation, lipid-lowering agents, etc)

  21. Treatments Reproductive desire (contraception, desired fertility, etc.) Clinical need (hirsutism, dysfunctional bleeding, etc.) Prognosis • PCOS is a chronic condition. No cure. • Management-alleviating the signs and symptoms to reduce morbidity.

  22. Treatments Desire Fertility Weight loss & Exercise- alone (even as little as 5% to 7%) may restore ovulation in up to 80% of overweight or obese patients Metformin- Restore ovulation/menses. 40% ovulate on Metformin 6 to 9 months needed for the full effect. ↑SHBG, ↓glucose production & ↑insulin sensitivity Clomiphene-induce ovulation. +Metformin or + Dexamethasone for adrenal androgen excess

  23. Treatments No Desire for Fertility OCP Antiandrogen Androgen receptor blockers (spironolactone, cyproterone, flutamide) 5-alpha-reductase inhibitors (finasteride) Hirsutism Mechanical or local hair removal (depilation and epilation) VANIQA (Topical eflornithine cream) Acne Topical antibiotics (erythromycin and clindamycin), Oral antibiotics (doxycycline, minocycline & erythromycin) Topical BENZOYL PEROXIDE Topical RETINOIDS Weight loss & Exercise Metformin

  24. Treatments Ovarian Diathermy (Drilling) -Laser fiber or electrosurgical needle punctures the ovary 4 to 10 times. -Up to 80 percent of patients will benefit -Anovulatory women may ovulate with clomiphene or Metformin therapy after ovarian drilling. Rarely, oophorectomy is a viable option for women not seeking fertility who exhibit signs and symptoms of ovarian hyperthecosis and accompanying severe hyperandrogenism

  25. Treatments Ovarian Diathermy (Drilling)

  26. Prevention • Weight loss and Metformin may prevent diabetes and atherosclerosis. • Lifestyle modification-physical activity and healthy diet • Family history-Screening at younger age Monitoring • Patients should be evaluated every 3 months for treatment response and development of any adverse effects. Once stable, monitoring is every 6 months.

  27. References Banaszewska B, Duleba A, Spaczynski R: Lipids in polycystic ovary syndrome: Role of hyperinsulinemia and effects of metformin. Am J Obstet Gynecol 194:1266, 2006 Azziz R, Woods KS, Reyna R, et al. The prevalence and features of the polycystic ovary syndrome in an unselectedpopulation. J Clin Endocrinol Metab. Jun 2004;89(6):2745-9 Boomsma CM, Eijkemans MJC, Hughes EG: A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome. Hum Reprod Update 12:673, 2006 Dokras A, Bochner M, Hollinrake E: Screening women with polycystic ovary syndrome for metabolic syndrome. Obstet Gynecol 106:131, 2005 Goldenberg N, Glueck C (2008). "Medical therapy in women with polycystic ovarian syndrome before and during pregnancy and lactation". Minerva Ginecol60 (1): 63–75

  28. Everyone For Everything

More Related